SCCT: Gadolinium-based contrast agents work for TAVR planning
AuntMinnie
JULY 21, 2024
Gadolinium-base contrast agents (GBCAs) can be used in aortic stenosis patients being considered for transcatheter aortic valve replacement (TAVR) who are contraindicated for iodinated contrast media, researchers have found. A team led by Emily Lippincott, MD, from Vanderbilt University found no adverse reactions to GBCAs in eight patients with a history of serious reactions or contraindications to iodinated contrast media.
Let's personalize your content